There were more patients in thepreconditioning group medicated with β-blockers (5 subjects) and statins (2subjects, no significant differences), whereas more control patients were medicatedwith insulin and metformin, in spite of the fact that the proportion of diabetes wassimilar in both groups. The gene discussed is INS; the disease is diabetes mellitus.